European Healthtech startup funding raised during September 2016.
In September 2016, 30 European Healthtech companies raised a combined €182M across 30 funding rounds, down 55.2% versus September 2015. Germany led by capital raised, and Fountain Healthcare Partners was the most active investor. Data as of 23 Aug 2026.
1 exit.
| Company | Stage | Date | Amount |
|---|---|---|---|
| IOmx Therapeutics | Series A | Sep 2016 | €40M |
| Spineart | Growth/Late | Sep 2016 | €30M |
| Artios | Series A | Sep 2016 | €29M |
| Vivasure Medical | Series C |
| Sep 2016 |
| €16M |
| Inflazome | Series A | Sep 2016 | €15M |
| Rigontec | Series A | Sep 2016 | €14M |
| Eyevensys | Series A | Sep 2016 | €9.0M |
| H4D | Series B | Sep 2016 | €6.7M |
| Seventeen | Series A | Sep 2016 | €4.2M |
| LeUnited Kingdomos Biotech | Early VC | Sep 2016 | €3.5M |
| Reapplix | Series A | Sep 2016 | €2.7M |
| Bioxis Pharmaceuticals | Early VC | Sep 2016 | €2.5M |
| Medherant | Early VC | Sep 2016 | €1.8M |
| Aifloo | Series A | Sep 2016 | €1.3M |
| Oncovet Clinical Research | Early VC | Sep 2016 | €1.3M |
